About Index Trending news
Analyze
Pricing
Silence Therapeutics

Silence Therapeutics

Work at Silence Therapeutics? Add yourself to this profile

Silence Therapeutics

We are a leader in the development & delivery of RNA therapeutics for the modulation of gene expression up as well as down. Publicly Listed, AIM:SLN.
Edit Profile
More info

Elsewhere

Also headquartered in London

Reuters Reuters BBC BBC Blockchain Blockchain SwiftKey SwiftKey Virgin Virgin Ubuntu Ubuntu Charlie Charlie Volkswagen Volkswagen Deliveroo Deliveroo HSBC HSBC

Companies in the same industry

Therachon AG Therachon AG numares AG numares AG Arsia Therapeutics Arsia Therapeutics Biomoti Biomoti Scholar Rock Scholar Rock Fulgent Diagnostics Fulgent Diagnostics Sirenas Marine Discovery Sirenas Marine Discovery Capricor Therapeutics Capricor Therapeutics Merus Merus Tioma Therapeutics Tioma Therapeutics

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1

Acquisitions 1
Add info
Latest funding
Venture capital
$58,200,000
Employees

Team size

10+
Locations
HQ
London, United Kingdom
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Silence Therapeutics makes some noise.